{"title":"印度辅助生殖技术使用情况。","authors":"Prathima Tholeti, Shubhashree Uppangala, Guruprasad Kalthur, Satish Kumar Adiga","doi":"10.1530/RAF-24-0079","DOIUrl":null,"url":null,"abstract":"<p><p>Historically, infertility has been stigmatized in the Indian society, primarily due to societal norms that equate marriage with procreation. In twentieth century, India focused primarily on over-fertility in its family planning programs, with little attention given to the complexities of infertility. The introduction of Assisted Reproductive Technology (ART) in the late 1970s made a global revolution, including in India, offering hope to infertile couples. Despite a significant rise in ART clinics offering a wide range of treatment options in the recent years, challenges remain, particularly regarding the affordability. In India, ART is typically dominated by the private sector as government support remains limited. Efforts to standardize ART practices, including the establishment of the National ART & Surrogacy Registry and ART act aim to regulate, improve outcomes and curb unethical practice. Despite these advancements, the high cost of treatment cycles and lack of insurance coverage limit many couples' ability to undergo fertility treatment. Addressing these issues requires a multifaceted approach, including policy reform, increased public awareness, and the development of affordable treatment options to ensure broader access to reproductive care across India.</p>","PeriodicalId":101312,"journal":{"name":"Reproduction & fertility","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11558918/pdf/","citationCount":"0","resultStr":"{\"title\":\"The landscape of assisted reproductive technology access in India.\",\"authors\":\"Prathima Tholeti, Shubhashree Uppangala, Guruprasad Kalthur, Satish Kumar Adiga\",\"doi\":\"10.1530/RAF-24-0079\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Historically, infertility has been stigmatized in the Indian society, primarily due to societal norms that equate marriage with procreation. In twentieth century, India focused primarily on over-fertility in its family planning programs, with little attention given to the complexities of infertility. The introduction of Assisted Reproductive Technology (ART) in the late 1970s made a global revolution, including in India, offering hope to infertile couples. Despite a significant rise in ART clinics offering a wide range of treatment options in the recent years, challenges remain, particularly regarding the affordability. In India, ART is typically dominated by the private sector as government support remains limited. Efforts to standardize ART practices, including the establishment of the National ART & Surrogacy Registry and ART act aim to regulate, improve outcomes and curb unethical practice. Despite these advancements, the high cost of treatment cycles and lack of insurance coverage limit many couples' ability to undergo fertility treatment. Addressing these issues requires a multifaceted approach, including policy reform, increased public awareness, and the development of affordable treatment options to ensure broader access to reproductive care across India.</p>\",\"PeriodicalId\":101312,\"journal\":{\"name\":\"Reproduction & fertility\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11558918/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reproduction & fertility\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1530/RAF-24-0079\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"REPRODUCTIVE BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reproduction & fertility","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1530/RAF-24-0079","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"REPRODUCTIVE BIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
从历史上看,不孕症在印度社会一直受到鄙视,这主要是由于将婚姻等同于生育的社会规范造成的。二十世纪,印度的计划生育计划主要关注过度生育问题,很少关注不孕不育的复杂性。20 世纪 70 年代末,辅助生殖技术(ART)的引入在全球(包括印度)掀起了一场革命,为不孕不育夫妇带来了希望。尽管近年来提供多种治疗方案的 ART 诊所大幅增加,但挑战依然存在,尤其是在经济承受能力方面。在印度,抗逆转录病毒疗法通常由私营部门主导,因为政府的支持仍然有限。为规范抗逆转录病毒疗法所做的努力,包括建立国家抗逆转录病毒疗法和代孕登记处以及制定抗逆转录病毒疗法法案,旨在规范、改善治疗效果并遏制不道德的做法。尽管取得了这些进步,但高昂的治疗周期费用和缺乏保险保障限制了许多夫妇接受生育治疗的能力。要解决这些问题,需要采取多方面的措施,包括政策改革、提高公众意识、制定负担得起的治疗方案,以确保在印度全国范围内提供更广泛的生殖保健服务。
The landscape of assisted reproductive technology access in India.
Historically, infertility has been stigmatized in the Indian society, primarily due to societal norms that equate marriage with procreation. In twentieth century, India focused primarily on over-fertility in its family planning programs, with little attention given to the complexities of infertility. The introduction of Assisted Reproductive Technology (ART) in the late 1970s made a global revolution, including in India, offering hope to infertile couples. Despite a significant rise in ART clinics offering a wide range of treatment options in the recent years, challenges remain, particularly regarding the affordability. In India, ART is typically dominated by the private sector as government support remains limited. Efforts to standardize ART practices, including the establishment of the National ART & Surrogacy Registry and ART act aim to regulate, improve outcomes and curb unethical practice. Despite these advancements, the high cost of treatment cycles and lack of insurance coverage limit many couples' ability to undergo fertility treatment. Addressing these issues requires a multifaceted approach, including policy reform, increased public awareness, and the development of affordable treatment options to ensure broader access to reproductive care across India.